41 results on '"Combaret, V."'
Search Results
2. Stimulation of the Immune System for the Therapy of Advanced Stage Neuroblastoma
3. Immunological Modifications Induced by IL2 Therapy in Thirteen Children with Advanced Neuroblastoma1
4. Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification
5. Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells
6. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
7. Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma
8. The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking
9. 372 Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting the dependence receptor TrkC-induced apoptosis
10. SFCE-05 – Cancérologie, hématologie, immunologie – Classification génomique dans le neuroblastome : utilité pour la prise en charge thérapeutique
11. Neuroblastome de l’enfant: challenges et perspectives
12. Quality Assessment of Genetic Markers Used for Therapy Stratification
13. Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification
14. Assessment of percutaneous fine needle aspiration cytology as a technique to provide diagnostic and prognostic information in neuroblastoma
15. LMCE3 Treatment Strategy: Results in 99 Consecutively Diagnosed Stage 4 Neuroblastomas in Children Older Than 1 Year at Diagnosis
16. Immunological and molecular detection of tumor contamination in leukapheresis products from children with disseminated neuroblastoma: implication for evaluation of tumor cell depletion after CD34 selection
17. Dépistage du neuroblastome en région Rhône-Alpes : données cliniques et biologiques, évolution des neuroblastomes de la cohorte (1990–1994)
18. False positive MIBG scan
19. Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma
20. Loss of chromosome 1p may have a prognostic value in localised Neuroblastoma: results of the French NBL 90 study
21. Screening for neuroblastoma in France: Methodological aspects and preliminary observations
22. Expression immunohistochimique des gènes TRKA et CD44 sur les tumeurs de patients porteurs de neuroblastome et leur signification clinique
23. Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression
24. Screening for neuroblastoma in France: Methodological aspects and preliminary observations
25. In vitro targeting and specific transfection of human neuroblastoma cells by chCE7 antibody-mediated gene transfer
26. Initial Management of Advanced Burkitt Lymphoma in Children: Is There Still a Place for Surgery?
27. A 5-year (1990–1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observations
28. Gangliosides protect human melanoma cells from ionizing radiation-induced clonogenic cell death
29. Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas.
30. Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin.
31. Evaluation of CD44 prognostic value in neuroblastoma: Comparison with the other prognostic factors
32. Isolated Intraspinal Relapse Of Neuroblastoma After Autolocous Bone Marrow Transplantation
33. CD44 -- A New Prognostic Marker for Neuroblastoma
34. Indication and limits of megatherapy and bone marrow transplantation in high-risk neuroblastoma: A single centre analysis of prognostic factors
35. Growth promoting activity of TNF on neuroblastoma cell lines
36. Expression of P-glycoprotein restricted to normal cells in neuroblastoma biopsies
37. Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocols
38. Bone marrow metastases in small cell lung cancer: detection with magnetic resonance imaging and monoclonal antibodies
39. Interleukin-2 with and without LAK cells in metastatic renal cell carcinoma: the Lyon first-year experience in 20 patients
40. Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation
41. IMMUNOMAGNETIC DEPLETION OF MALIGNANT CELLS FROM AUTOLOGOUS BONE MARROW GRAFT: FROM EXPERIMENTAL MODELS TO CLINICAL TRIALS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.